
Incannex Healthcare's IHL-42X Shows Promising Phase 2 Results for Sleep Apnea Treatment
Incannex Healthcare Inc. reports statistically significant reductions in sleep apnea severity with its IHL-42X treatment, positioning the company favorably for Phase 3 trials and potential commercialization while strengthening its financial position through strategic warrant repurchases.
Read full story


























